Global Non-invasive Prenatal Testing Market

Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market Definition

The market for respiratory masks (N95 respirators, surgical masks, and others) consists of sales of N95 respirators, surgical masks and other face masks used as personal protective equipment to protect the wearer from airborne particles and from liquid contaminating the face, or to ensure the wearer does not contaminate the area around them. The market consists of revenue generated by the company’s manufacturing the N95 respirators and surgical face masks by the sale of these products. N95 respirator is defined as a personalized protective respiratory device that protects the wearer from airborne and liquid contamination. These types of masks are predominantly used in the industrial or the healthcare sector, to protect workers from various respiratory and airborne diseases. N95 respirator is designed to filter at least 95% of airborne particles. Surgical masks are loose fitting, usually disposable devices which are commonly used in healthcare settings to protect doctors and other medical staff from the risk of an infection. These are single-use items and are usually disposed after being used once. Comfort masks or dust masks are a flexible pad held over the nose and mouth by elastic or rubber straps to protect the user against dusts encountered during construction or cleaning activities. They are also increasingly used in high pollution regions.

Portable Ultrasound Devices Market Definition

The portable ultrasound devices market consists of the sales of portable ultrasound devices and related services by entities (organizations, sole traders and partnerships) that manufacture portable ultrasound devices for use in the healthcare industry. Ultrasound imaging is an imaging method in which high frequency sounds waves, usually 1-20 MHz, are transmitted into the body, encountering tissues, organs, fluids, gases, and bones. The waves are both absorbed and reflected by the different materials and interfaces within the human body. The reflection or echo, then returns back to the transmitter, forming an image of the target. A portable ultrasound device is a diagnostic imaging equipment that is small in size and light in weight, and can be moved easily from one place to other. These devices are easy to carry and useful for short duration treatments.

Portable X-ray Devices Market Definition

The portable X-ray devices market consists of the sales of portable X-ray devices by entities (organizations, sole traders and partnerships) that manufacture portable X-ray devices for use in the healthcare industry. A portable X-ray device is a wireless digital X-ray imaging device for mobile health providers such as doctors and first aid workers in field situations, during home care and in old age homes, as well as for medically oriented aid organizations, ships and offshore platforms. X-rays are a form of electromagnetic radiation of high energy and very short wavelength, which are able to pass through materials and solid objects, including the body. X-rays are used in a wide array of applications in a range of industries such as healthcare, security and art.

The disposable hospital supplies market consists of the sale of disposable hospital supplies and related services. Disposable hospital supplies are products manufactured for single usage and include supplies such as face masks, gowns and gloves among others. The global disposable hospital supplies market is expected to grow from $59.7 billion in 2019 to 74.6 billion in 2020 at a compound annual growth rate (CAGR) of 25.0%. The significant growth is mainly due to the COVID-19 outbreak and the measures to contain it. Disposables including masks, wipes, disposable hospital room products, and other standard examination supplies are in huge demand by the care providers with the growing number of COVID-19 cases. On the other hand, face masks are used by population worldwide other than just care providers and patients, as masks provide effective protection against respiratory infections. However, there is a supply and demand gap due to restrictive containment measures impacting the supply chain that is likely challenging the growth. The market is then expected to stabilize and reach $93.02 billion in 2023 at a CAGR of 7.65%. North America was the largest region in the hospital disposable market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The disposable hospital supplies market covered in this report is segmented by type into gloves, drapes, gowns, needles, syringes, procedure kits and trays, bandages, masks. It is also segmented by product into diagnostic supplies, dialysis consumables, radiology consumables, infusion products, incubation & ventilation supplies, hypodermic products, sterilization consumables, non-woven medical supplies, wound care consumables, others, and by end-users into hospitals, clinics/physician offices, assisted living centers & nursing homes, ambulatory surgery centers, research institutes. The increasing number of COVID-19 cases across the globe is projected to surge the demand for disposable hospital supplies. The rapid surge in coronavirus cases is generating huge demand for personal protective equipment (PPE) and other disposable supplies to protect healthcare workers from infections in their daily operations. According to the World Health Organization report published on the 3rd July 2020, there were 10,719,946 COVID-19 confirmed cases including 323,412 deaths globally. Therefore, the rise in the number of cases across the globe and the growing need for healthcare workers to be protected against the spread of the virus are anticipated to boost the demand for disposable hospital supplies market over the forecast period. The government agencies are extending support to PPE manufacturers and suppliers to ensure the smooth flow of medical supplies. For instance, UNICEF launched a joint tender in April for PPE supplies during 2020 on behalf of several UN organizations. The government initiatives to help medical supplies manufacturers and suppliers are likely to play a vital role in aiding the manufacture of essential medical supplies, which in turn, is predicted to shape the disposable hospital supplies market in the forthcoming years. Rising environmental concerns associated with the improper disposal of non-reusable hospital supplies is expected to limit the growth of the disposable hospital supplies market. In healthcare facilities, disposable gloves and gowns are widely used to maintain a sterile environment and reduce the risk of spreading infections during the pandemic. Improper disposal of supplies including gloves, gowns, masks and other personal protective equipment used during the monitoring and treatment of COVID-affected patients poses a high risk of virus spread. Environmental regulatory bodies are imposing stringent rules for proper and managed disposal of hospital wastes. For instance, in the USA, contaminated gloves are disposed of in orange-lidded containers or orange bags based on the law guidance laid by the Royal College of Nursing. The increase in production capacities by various players dealing in disposable hospital supplies market amid coronavirus outbreak is a leading trend shaping the growth of the industry. For instance, on 15th May 2020, Honeywell announced plans to build a new production line in Scotland, UK with the capacity of producing 4.5 million FFP3 and FFP2 disposable face masks every month. These masks are likely to assist the UK government’s response to the COVID-19 outbreak. Thus, the expansion of production capacities to meet the increased demand for disposable medical supplies is projected to generate higher revenues for the market during 2020. In April 2020, Eclipse Automation Inc. announced a collaboration with Harmontronics Automation of Suzhou, China to manufacture, distribute and sell the Harmontronics fully automated N95 Vertical Flat-Fold Respirator Mask production line system across North America. Harmontronics Automation is a factory automation solution provider for small and precise product manufacturing.

The sterilization equipment and disinfectants market consist of sales of sterilization equipment and disinfectants which are used in the decontamination of microorganisms. The revenue of sterilization equipment and disinfectants market is mainly through the sales of sterilization equipment which includes heat sterilizers, low-temperature sterilizers, radiation sterilizers and filtration sterilizers and disinfectants which include high-level, intermediate-level and low-level disinfectants. The manufactures of sterilization equipment and disinfectants market are primarily engaged in manufacturing equipment which are used for decontamination by physical, chemical and mechanical methods by clinical laboratories, pharmaceutical companies, hospital and clinics. The global sterilization equipment and disinfectants market is expected to grow from $7.14 billion in 2019 to 8.05 billion in 2020 at a compound annual growth rate (CAGR) of 12.7%. The remarkable growth is mainly due to the COVID-19 outbreak and the measures to contain it. Coronavirus infection in most instances is transmitted through respiratory droplets and through contact with contaminated surfaces/objects. The virus gets easily inactivated by chemical disinfectants and sterilization of medical equipment prior to use. While sterilization is commonly used in healthcare settings, disinfectants are currently being widely used by the general public worldwide. The market is then expected to stabilize and reach $9.85 billion in 2023 at a CAGR of 6.95%. North America was the largest region in the sterilization equipment and disinfectants market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The sterilization equipment and disinfectants market covered in this report is segmented by product type into sterilization equipment, disinfectants. It is also segmented by method into physical method, chemical method, mechanical method, and by end-user into hospitals and clinics, pharmaceutical companies, clinical laboratories. Government regulations to combat COVID-19 situation is expected to boost market growth during the forecast period. In March 2020, US EPA announced the acceleration of reviewing the submissions by disinfectant manufacturers requesting to add Emerging Viral Pathogens Claims to the already existing surface disinfectant labels. EPA also took steps against supply chain challenges by increasing the flexibility of procurement of inert ingredients and even some active ingredients listed in List N – “Disinfectants for Use Against SARS-CoV-2”, without checking for agency`s approval. The manufacturers are also allowed to release the disinfectants by just notifying the changes adopted in formulation and manufacturing facilities without waiting for US EPA approval. EPA has also created platforms to identify and protect consumers from fraudulent Coronavirus Disinfectants Claims. Governments’ steps against COVID-19 will focus on the enhancement of the production, approval and safety of consumers and mitigate the supply chain challenges, which will increase the revenue of the market. Shortage in the supply of ethylene oxide gas sterilized medical equipment is expected to hinder the market growth. Ethylene oxide sterilization is a widely used method for sterilization of medical devices. More than 20 billion devices sold in the USA every year are sterilized with ethylene oxide, accounting for approximately 50% of devices that require sterilization. However, the FDA released a statement regarding the temporary closure of few sterilization facilities using ethylene oxide due to safety concerns posed by the local residents as the exposure to this gas leads to cancer and neurological conditions. This closure is likely to impact the supply of sterile medical devices. The shortage in the supply of ethylene oxide-sterilized medical devices is, therefore, challenging this market’s growth. Sustainable solutions such as repeat sterilization of medical equipment including personal protective equipment are expected to boost the market during the forecast period. As there is a shortage in the supply of PPE to the hospitals offering services to COVID-19 patients, few companies have come up with repeat sterilization of used PPE like gowns and masks. In April 2020, San-I-Pak, a California based company that manufactures equipment for high-end waste treatment, has sterilization equipment that sterilizes used medical equipment like PPE including isolation gown, 3M safety glasses, several non-branded polycarbonate glasses and surgical masks. Similarly, Battelle Memorial Institute, a non-profit research organization, is aiming at re-using the N95 respirator masks by sterilizing the N95 respirator masks as long as the masks are not made of cellulose. Battelle has been funded with $400 million by the Defense Logistics Agency under US HHS to provide decontamination of N95 across 60 sites of the USA. Following the scarcity of PPE, decontamination or sterilization of PPE rather than replacing this vital medical equipment is expected as a growth area. In October 2019, Stryker, a US-based global manufacturer of medical technology acquired TSO3 Inc., a Canada-based company that encloses the research, development, licensing, production, maintenance and sale of sterilization products and accessories for heat-sensitive medical devices. This acquisition will provide the expertise and the financial resources to best help TSO3 achieve its full potential in sterilization technology for medical devices in healthcare settings.

Nebulizers Market Definition

The nebulizer devices market consists of sales of nebulizers by entities (organizations, sole traders and partnerships) that produce nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis and COPD. A nebulizer is a drug delivery device that changes medication from a liquid to a mist form (fine droplets or aerosols) for direct inhalation into the lungs. The components that make up a nebulizer include air filters, tubing, and compressor to deliver medication to the user in a vaporized form.

The COVID-19 rapid test kits market consists of sales of rapid test kits used for COVID-19 diagnosis and detection. The COVID-19 rapid test kits are either rapid antigen test kits or rapid antibody test kits manufactured by the entities that manufacture in-vitro rapid diagnostic tests in the medical equipment industry. The companies involved in manufacturing these rapid test kits are primarily engaged in designing, research and production of the rapid test kits which are used in hospitals and clinics, home care, diagnostic laboratories and more. The global COVID-19 rapid test kits market is expected to reach $3.52 billion by the end of 2020 and $4.22 billion by 2021, growing at a compound annual growth rate (CAGR) of 19.7%. The significant growth rate is mainly due to the surge in demand for the rapid test kits for early detection and treatment of COVID-19 globally. The market is then expected to stabilize and reach $4.73 billion in 2023 at a CAGR of 10.36%. North America is expected to be the largest region in the COVID-19 rapid test kits market in 2020. Asia-pacific is expected to be the fastest-growing region in the forecast period. The COVID19 rapid test kits market covered in this report is segmented by test type into rapid antigen test, rapid antibody test, others. It is also segmented by kit type into equipment and extraction kits, reagents, by specimen type into nasopharyngeal swab, oropharyngeal swab, nasal swab, blood sample, others, and by end-users into hospitals and clinics, diagnostic laboratories, home care, others. Government regulations and steps to provide diversified diagnostic approaches are expected to boost the market growth during the forecast period. Better diagnostics facilities are required to overcome the increasing spread of Covid-19 cases globally, particularly in the rising geriatric population. In March 2020, the FDA has approved decentralized testing platforms to enlarge the testing capabilities across healthcare centres in the US. FDA issued a policy, under which, states can set up their platforms for authorizing the tests developed and the laboratories developing these tests need not engage with the FDA instead will engage with the respective state authorities. National Institutes of Health (NIH) has announced a Rapid Acceleration of Diagnostics (RADx), which is a fast track program for Covid-19 test development and distribution procedure under which it will be funding up to $500 million for the development of innovative SARS-CoV-2 diagnostic tests. Robust funding and investments by the public as well as private agencies for the rapid and innovative development of diagnostics for Covid-19 are expected to further boost the market. Product recalls due to quality control issues are expected to hinder the market growth during the forecast period. Rapid medical device approval due to present COVID-19 scenario paves ways to challenges such as product recalls due to safety, efficacy and quality issues. In May 2020, Spartan Bioscience`s rapid COVID-19 diagnostic kits which were approved with fast track designation in April 2020 were recalled due to efficacy concerns posed by Health Canada regarding its proprietary swab. Health Canada paused the regulatory approval of the test kit and till then permitted Spartan rapid test kit to be used for research purposes only. In April 2020, India recalled rapid-antibody testing kits imported from China due to efficacy issues, and all the procurement orders from China have also been cancelled. The lack of proper screening and quality assurance along with fast track approval is expected to increase the product recalls which will hinder the market growth. The incorporation of Artificial Intelligence (AI) algorithms with the rapid diagnostic test kits is expected to boost market growth during the forecast period. In March 2020, Surgisphere announced the availability of a rapid diagnostic intelligent tool for COVID-19 that it developed to utilize three laboratory tests with a sensitivity of 93.7% and specificity of 99.9% to identify patients who are likely to be infected with Coronavirus. Surgisphere created a decision tree analysis to identify patients who are likely to be infected with Coronavirus, using clinical lab data of patients in the QuartzClinical platform which is a cloud-based healthcare data analytics platform. Early detection of patients results in faster treatment and thus saving more lives which can be achieved through the use of artificial intelligence along with the rapid diagnosis test. In April 2020, Hememics Biotechnologies Inc., a US-based research and development company announced a partnership with Biomedical Research and Development Authority (BARDA) to develop a rapid antigen and antibody diagnostic tool which is Bluetooth-enabled. Under the partnership, BARDA will contribute $638,000 to Hememics for the manufacturing and scaling up production of the immune biosensor platform, which is a Bluetooth-enabled rapid diagnostic kit that screens people within 60 seconds with a single drop of blood or mucus. Biomedical Advanced Research and Development Authority (BARDA) is an office of US HHS, which takes measures against bioterrorism, epidemic and pandemic diseases.

The healthcare personal protective equipment market consists of the sale of personal protective equipment used in healthcare settings. The market consists of revenue generated by the companies that manufacture healthcare personal protective equipment by the sales of these products. The global healthcare personal protective equipment (PPE) market is expected to grow from $5.99 billion in 2019 to $7.83 billion in 2020 at a compound annual growth rate (CAGR) of 30.80%. The significant growth is mainly due to the COVID-19 outbreak and the measures to contain it. PPE are in huge demand by the care providers owing to the growing number of COVID-19 cases. However, there is a supply and demand gap due to restrictive containment measures that is challenging market growth. The market is then expected to stabilize and reach $11.45 billion in 2023 at a CAGR of 13.5%. North America was the largest region in the healthcare personal protective equipment market in 2019. Asia-Pacific is expected to be the fastest-growing regions in the forecast period. The healthcare personal protective equipment market covered in this report is segmented by product into head, eye & face protection, hearing protection, protective clothing, respiratory protection, protective footwear, fall protection, hand protection, and by end-use into hospitals and clinics, ambulatory surgical centers, academic and research institutes, diagnostic laboratories, others. The increasing number of COVID-19 cases across the globe is projected to surge the demand for healthcare personal protective equipment. The rapid surge in coronavirus cases is generating huge demand for PPEs to protect health workers from infections in their daily medical operations. According to the World Health Organization report published on the 3rd July 2020, there were 10,719,946 COVID-19 confirmed cases globally. The demand for PPE including gloves, face protection masks or face shield, goggles, gloves, gown or coverall, head cover, and boots surged due to this global pandemic to ensure the safety of healthcare workers who are at the frontline combating the disease spread. Therefore, the rise in the number of coronavirus cases across the globe and the growing need for healthcare workers to protect against the spread of the virus is anticipated to drive the growth of the personal protective equipment market over the forecast period. The governmental agencies are extending support to PPE manufacturers and suppliers to ensure the smooth flow of medical supplies. For instance, UNICEF launched a joint tender in April for PPE supplies during 2020 on behalf of several UN organizations. Thus, the government initiatives to help medical supplies manufacturers and suppliers are likely to play a vital role in hurdle-less supply of essential medical supplies, which in turn, is predicted to drive the disposable hospital supplies market in the forthcoming years. Disruptions in the global supply chain of personal protective equipment (PPE) is hindering the market growth. Ever since the COVID-19 outbreak, the supply chain for PPE has not been adequate to meet the surge in demand. There is a shortage of supply, particularly for medical masks and respirators. Other PPE including gloves, gowns and goggles have also not been sufficient to handle the increasing number of cases. The WHO estimated that 89 million medical masks are required each month, along with 76 million examination gloves and 1.6 million medical goggles for the COVID-19 response. The shortage is mainly due to the restrictive containment measures involving social distancing and remote working, and the closure of industries and other commercial activities. The entire supply chain from production to international trade has been impacted. Therefore, the current global stockpile is inadequate to handle the existing cases worldwide. The disruption in the global supply chain of raw materials of PPE due to extending lockdown and closure of companies manufacturing and supplying them, and constraints in supply and logistics including ban on export in most of the countries is hindering the manufacturing of PPE, despite its high demand. In April, 2020, 3M, a renowned PPE manufacturer, collaborated with Ford for producing a powered air purifying respirator (PAPR) design and partnered with a diesel engine manufacturer, Cummins, for additional high efficiency particulate filters for using in its PAPRs in order to meet the increased demand for PPEs during the pandemic outbreak to protect health care professionals on the front lines fighting COVID-19. Cummins uses diesel engine filters to make PAPRs filter as guided by the 3M design whereas Ford increases the manufacturing capacity of existing 3M PPE products.